Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Moodys
Baxter
AstraZeneca
McKinsey

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Patent: 9,458,089

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,458,089
Title:Phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering active agents
Abstract: The present invention relates to particular phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering biologically active agents to a target. These compounds are well suited for forming non-covalent mixtures with active agents for oral, intracolonic, pulmonary, and other routes of administration to animals.
Inventor(s): Mustata; Gabriela (Roseland, NJ), Pan; Dahua (Roseland, NJ), Gschneidner; David (Roseland, NJ)
Assignee: Emisphere Technologies, Inc. (Roseland, NJ)
Application Number:14/423,319
Patent Claims:see list of patent claims

Details for Patent 9,458,089

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Start Trial Emisphere Technologies, Inc. (Roseland, NJ) 2032-08-23 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Start Trial Emisphere Technologies, Inc. (Roseland, NJ) 2032-08-23 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Start Trial Emisphere Technologies, Inc. (Roseland, NJ) 2032-08-23 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Start Trial Emisphere Technologies, Inc. (Roseland, NJ) 2032-08-23 RX Orphan search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20   Start Trial Emisphere Technologies, Inc. (Roseland, NJ) 2032-08-23 RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 003 1991-02-20   Start Trial Emisphere Technologies, Inc. (Roseland, NJ) 2032-08-23 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Johnson and Johnson
Harvard Business School
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.